LEVA Trademark

Trademark Overview

On Tuesday, September 3, 2013, a trademark application was filed for LEVA with the United States Patent and Trademark Office. The USPTO has given the LEVA trademark a serial number of 86054360. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, December 15, 2022. This trademark is owned by Remendium Labs LLC. The LEVA trademark is filed in the Medical Instrument Products category with the following description:

Medical devices for the biometric monitoring of Kegel exercises for the diagnosis, prevention and treatment of pelvic dysfunction including urinary incontinence
leva

General Information

Serial Number86054360
Word MarkLEVA
Filing DateTuesday, September 3, 2013
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, December 15, 2022
Registration Number5036872
Registration DateTuesday, September 6, 2016
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 11, 2014

Trademark Statements

Translation of Words in MarkThe English translation of the word "LEVA" in the mark is "it weighs".
Goods and ServicesMedical devices for the biometric monitoring of Kegel exercises for the diagnosis, prevention and treatment of pelvic dysfunction including urinary incontinence

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, September 11, 2013
Primary Code010
First Use Anywhere DateSunday, June 30, 2013
First Use In Commerce DateWednesday, July 1, 2015

Trademark Owner History

Party NameAXENA HEALTH, INC.
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressAUBURNDALE, MA 02466
Party NameRENOVIA INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressBOSTON, MA 02210
Party NameRemendium Labs LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBaton Rouge, LA 70803
Party NameRemendium Labs LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBaton Rouge, LA 70803
Party NameRemendium Labs LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBaton Rouge, LA 70803

Trademark Events

Event DateEvent Description
Sunday, December 15, 2013NON-FINAL ACTION E-MAILED
Friday, September 6, 2013NEW APPLICATION ENTERED
Wednesday, September 11, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, December 15, 2013ASSIGNED TO EXAMINER
Sunday, December 15, 2013NON-FINAL ACTION WRITTEN
Sunday, December 15, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 25, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 25, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 17, 2014ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, July 17, 2014ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, July 22, 2014TEAS PETITION TO REVIVE RECEIVED
Tuesday, July 22, 2014PETITION TO REVIVE-GRANTED
Tuesday, July 22, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 22, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 22, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 22, 2014NOTICE OF REVIVAL - E-MAILED
Wednesday, August 13, 2014NON-FINAL ACTION WRITTEN
Wednesday, August 13, 2014NON-FINAL ACTION E-MAILED
Wednesday, August 13, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 16, 2014EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Tuesday, September 16, 2014EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Tuesday, September 16, 2014NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Wednesday, September 17, 2014ASSIGNED TO LIE
Wednesday, September 17, 2014COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Thursday, September 25, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 2, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 2, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 3, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 8, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 22, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 11, 2014PUBLISHED FOR OPPOSITION
Tuesday, November 11, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 6, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 18, 2015SOU TEAS EXTENSION RECEIVED
Thursday, June 18, 2015SOU EXTENSION 1 FILED
Wednesday, July 15, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 22, 2015SOU EXTENSION 1 GRANTED
Thursday, July 23, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 9, 2015SOU TEAS EXTENSION RECEIVED
Wednesday, December 9, 2015SOU EXTENSION 2 FILED
Sunday, January 17, 2016SOU EXTENSION 2 GRANTED
Tuesday, January 19, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 6, 2016TEAS STATEMENT OF USE RECEIVED
Monday, June 6, 2016USE AMENDMENT FILED
Monday, July 11, 2016STATEMENT OF USE PROCESSING COMPLETE
Friday, July 29, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, July 30, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 6, 2016REGISTERED-PRINCIPAL REGISTER
Wednesday, July 25, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, October 17, 2018ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, September 6, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, June 2, 2022TEAS SECTION 8 & 15 RECEIVED
Thursday, December 15, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, December 15, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, December 15, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, April 12, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Saturday, September 6, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

leva pelvic treatment dysfunction including incontinence urinary prevention diagnosis biometric devices